Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.02 is 35% below its 5-year average of 1.57, near the low end of its 5-year range (1.02–3.73).
As of the fiscal period ended Tuesday, June 30, 2026. 23.42% below its 12-month average of 1.34.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.02.
QUICK RATIO (ACID-TEST)
1.02
QUICK RATIO (ACID-TEST) AVG TTM
1.34
QUICK RATIO (ACID-TEST) AVG 3Y
1.38
QUICK RATIO (ACID-TEST) AVG 5Y
1.57
QUICK RATIO (ACID-TEST) AVG 10Y
3.28
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-23.42%
CURRENT VS 3Y AVG
-25.87%
CURRENT VS 5Y AVG
-35.02%
CURRENT VS 10Y AVG
-68.80%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-69.52%
vs the sector median at left
Xeris Biopharma Holdings, Inc.
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.02
TTM Avg
1.34
3Y Avg
1.38
5Y Avg
1.57
Market Cap
$1.74B
Quick Ratio (Acid-Test)
10.63
TTM Avg
5.62
3Y Avg
5.25
5Y Avg
6.00
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.79
3Y Avg
1.95
5Y Avg
2.14
Market Cap
$1.73B
Quick Ratio (Acid-Test)
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$1.75B
Quick Ratio (Acid-Test)
1.78
TTM Avg
1.68
3Y Avg
1.66
5Y Avg
1.61
Market Cap
$1.71B
Quick Ratio (Acid-Test)
5.08
TTM Avg
6.50
3Y Avg
5.46
5Y Avg
6.20
Market Cap
$1.77B
Quick Ratio (Acid-Test)
8.30
TTM Avg
3.78
3Y Avg
3.78
5Y Avg
3.78
Market Cap
$1.71B
Quick Ratio (Acid-Test)
1.07
TTM Avg
0.89
3Y Avg
0.95
5Y Avg
0.97
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | $1.74B | 1.02 | 1.34 | 1.38 | 1.57 |
| Absci Corporation (ABSI)vs › | $1.74B | 10.63 | 5.62 | 5.25 | 6.00 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 1.70 | 1.79 | 1.95 | 2.14 |
| Novocure Ltd (NVCR)vs › | $1.74B | 2.70 | 2.06 | 4.13 | 5.41 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | 6.65 | 5.42 | 7.28 | 7.47 |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.78 | 1.68 | 1.66 | 1.61 |
| Personalis, Inc. (PSNL)vs › | $1.71B | 5.08 | 6.50 | 5.46 | 6.20 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | 8.30 | 3.78 | 3.78 | 3.78 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 1.07 | 0.89 | 0.95 | 0.97 |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.70B | 9.93 | 5.91 | 4.26 | 4.26 |
Quick Ratio
1.02
Excludes inventory
Current Ratio
1.45
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.02 |
| 2026-03-31 | 1.50 |
| 2025-12-31 | 1.57 |
| 2025-09-30 | 1.35 |
| 2025-06-30 | 1.24 |
| 2025-03-31 | 1.17 |
| 2024-12-31 | 1.19 |
| 2024-09-30 | 1.29 |
| 2024-06-30 | 1.69 |
| 2024-03-31 | 1.81 |
| 2023-12-31 | 1.23 |
| 2023-09-30 | 1.38 |
| 2023-06-30 | 1.50 |
| 2023-03-31 | 1.68 |
| 2022-12-31 | 2.20 |
| 2022-09-30 | 1.88 |
| 2022-06-30 | 2.22 |
| 2022-03-31 | 2.42 |
| 2021-12-31 | 1.57 |
| 2021-09-30 | 2.95 |
| 2021-06-30 | 3.73 |
| 2021-03-31 | 5.40 |
| 2020-12-31 | 5.10 |
| 2020-09-30 | 5.83 |
| 2020-06-30 | 6.65 |
| 2020-03-31 | 4.72 |
| 2019-12-31 | 3.12 |
| 2019-09-30 | 5.96 |
| 2019-06-30 | 6.00 |
| 2019-03-31 | 11.45 |
| 2018-12-31 | 11.59 |
| 2018-09-30 | 16.53 |
| 2018-06-30 | 14.91 |
| 2018-03-31 | 6.51 |
| 2017-12-31 | 9.06 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
